Not Yet Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT06988319
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Sponsor: Oregon Health and Science University
Conditions
Chronic Pelvic Pain
Interventions
Psilocybin (Usona Institute)
Updated 2 times since 2025 Last updated: Oct 8, 2025 Started: Jan 1, 2026 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06988319, this PHASE1 trial focuses on Chronic Pelvic Pain and remains actively recruiting participants. Sponsored by Oregon Health and Science University, it has been updated 2 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Nov 2025 — Present [monthly]
Not Yet Recruiting PHASE1
-
Jun 2025 — Nov 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Oregon Health and Science University
- Portland Psychotherapy Clinic, Research, and Training Center
Data source: Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .